Skyharbour's Partner Mustang Energy Corp. Announces Results of TDEM Survey Over the 914W Property GlobeNewswire November 06, 2025 Vancouver, BC, Nov. 06, 2025 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce that partner company Mustang Energy Corp. (“Mustang”) received the results of a […]

Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy GlobeNewswire November 06, 2025 – Innovation Passport award facilitates accelerated time to market and helps expedite patient access to transformative new medicines – – New Innovative Licensing and Access Pathway

STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion GlobeNewswire November 06, 2025 HORSHAM, Pa., Nov. 06, 2025

BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated with One Year of ORLADEYO(R) (berotralstat) GlobeNewswire November 06, 2025 – Findings highlight negative psychosocial impact of HAE attacks and resulting ED/hospital visits on pediatric patients and their caregivers – – ORLADEYO

VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update GlobeNewswire November 06, 2025 Company is progressing its previously initiated strategic review evaluating a range of options to maximize shareholder value, including assessment of internal pipeline opportunities and broader strategic alternatives 12-week, non-clinical toxicology study of VYN202 in dogs to remedy the partial

Upexi to Host First Quarter 2026 Earnings Call on November 11th at 5:30 p.m. ET GlobeNewswire November 06, 2025 TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it plans to host a conference

Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors GlobeNewswire November 06, 2025 Exclusive collaboration and license agreement focuses on advancing novel T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100 series of Immuno-STATs(R) Novel therapeutic approach is designed to enable in vivo expansion and activation

Feed a Family of 10 for Under $40 this Thanksgiving: Stop & Shop Introduces One of the Season's Best Dinner Deals With a competitive meal deal, a Lowest Price Guarantee on turkeys, and savings all month long, better value starts at Stop & Shop this holiday season GlobeNewswire November 06, 2025 QUINCY, Mass., Nov. 06,

LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced financial results for the third quarter ended on September 30, 2025 and provided recent corporate updates. “Following our recent initial

MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights GlobeNewswire November 06, 2025 Reported positive topline results from the Phase 2 Avail(TM) trial of once-weekly canvuparatide in hypoparathyroidism (HP) Completed upsized public offering, raising approximately $200 million in gross proceeds $391.7 million in cash, cash equivalents and marketable securities as of September